Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care

Thromb Res. 2020 Nov:195:226-227. doi: 10.1016/j.thromres.2020.08.010. Epub 2020 Aug 9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants* / pharmacology
  • Anticoagulants* / therapeutic use
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections*
  • Critical Care
  • Heparin* / therapeutic use
  • Humans
  • Incidence
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2

Substances

  • Anticoagulants
  • Heparin